1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment | Patent Publication Number 20140377363

US 20140377363 A1
Patent NumberUS 08969355 B2
Application Number14480949
Filled DateSep 9, 2014
Priority DateJun 16, 2006
Publication DateDec 25, 2014
Original AssigneeH. Lundbeck As
Current AssigneeH. Lundbeck As
Inventor/ApplicantsHeidi Lopez de Diego
Tine Bryan Stensbol
Arne Mork
Benny Bang-Andersen
Nicholas Moore
Rene Holm
Andre Faldt
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.